EPA released new Guidance for products adding residual efficacy claims
After the onset of COVID-19, residual antimicrobial products became increasingly popular. In response to the demand, EPA issued interim guidance and test methods for public comment in October of 2020. On October 7, 2022, EPA released the final guidance and test methods required to pursue residual efficacy claims on antimicrobial product labels. Registrants have 1 year to implement the new Guidance but may do so sooner if preferred. Any protocols signed after October 7, 2023 (next year) must comply with the new Guidance.
Per EPA’s guidelines, “products with residual efficacy claims fall into two major categories: (1) disinfectants that also provide residual efficacy, and (2) supplemental residual antimicrobial products (e.g., coatings, paints, solid surfaces) that do not meet EPA’s standards for disinfectants but are intended to be used as a supplement to standard disinfection practices including List N disinfectants.” Specific details on this guidance can be found here.
How can TSG help?
Looking for regulatory support as you pursue residual efficacy claims for your antimicrobial products? TSG’s antimicrobial efficacy expert, Millie Brutofsky, can assist your company with navigating the latest efficacy guidelines. Want to speak with Millie? Get in touch with us: [email protected]
Share via:
